Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,269 public trials 1,193 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage

NCT00887159

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Small Cell Lung Carcinoma, +9 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • The Medical Center of Aurora Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
View all 301 locations
View Trial Details
Completed

Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer

NCT01642251

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +23 more
Locations
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Rocky Mountain Cancer Centers-Aurora Aurora, Colorado, United States
  • The Medical Center of Aurora Aurora, Colorado, United States
View all 428 locations
View Trial Details
Completed

Clinical and Molecular Study With Digital Support of Patients With Inoperable Lung Cancer

NCT05372081

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Ygeia Hospital Psychikó, Attica, Greece
  • MITERA Hospital Athens, Marousi, Greece
  • General University Hospital of Larissa Larissa, Mezourlo, Greece
  • 3rd Dept of Medical Oncology, Agii Anargiri Cancer Hospital Athens, Nea Kifisia, Greece
View all 15 locations
View Trial Details
Completed

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

NCT00324805

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
View all 1169 locations
View Trial Details
Completed

Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy

NCT00693992

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Veteran's Administration Medical Center Little Rock, Arkansas, United States
View all 484 locations
View Trial Details
Completed

A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010

NCT05867121

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +20 more
Locations
  • UCLA University of California Los Angeles Los Angeles, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
  • Thomas Jefferson University Philadelphia, Pennsylvania, United States
  • St Vincent'S Hospital Darlinghurst, New South Wales, Australia
View all 27 locations
View Trial Details
Completed

A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

NCT04623775

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Local Institution - 0160 Duarte, California, United States
  • Local Institution - 0081 Orange, California, United States
  • Local Institution - 0139 New Haven, Connecticut, United States
  • Local Institution - 0153 Jacksonville, Florida, United States
View all 125 locations
View Trial Details
Completed

Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer

NCT04475939

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • GSK Investigational Site Fullerton, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Lone Tree, Colorado, United States
  • GSK Investigational Site Norwich, Connecticut, United States
View all 188 locations
View Trial Details

Related conditions